SHA:600161 Market Cap

SHA:600161 has a market cap or net worth of 31.66 billion as of March 9, 2026. Its market cap has decreased by -23.18% in one year.

Market Cap

31.66B

Enterprise Value

33.48B

Revenue

6.42B

Ranking

n/a

PE Ratio

24.27

Stock Price

16.01

Market Cap Chart

Since March 8, 2000, SHA:600161's market cap has increased from 3.95B to 31.66B, an increase of 701.96%. That is a compound annual growth rate of 8.33%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	31.66B	-2.02%
Dec 31, 2025	32.31B	-20.29%
Dec 31, 2024	40.54B	-20.49%
Dec 29, 2023	50.98B	30.38%
Dec 30, 2022	39.10B	-1.67%
Dec 31, 2021	39.77B	-23.98%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Xiamen Amoytop Biotech	28.63B
Asymchem Laboratories (Tianjin)	35.00B
Hualan Biological Engineering	27.92B
Sunshine Guojian Pharmaceutical (Shanghai)	35.97B
Chongqing Zhifei Biological Products	38.68B
Hebei Changshan Biochemical Pharmaceutical	39.43B
Yili Chuanning Biotechnology	24.29B
Shanghai RAAS Blood Products	41.21B

Market Cap Rankings